TechNavio today launched its report, Global Endocrinology Drugs Market 2012-2016, based on an in-depth analysis covering the Americas, and the EMEA and APAC regions. The report aims to aid decision makers’ understanding of the significant trends impacting this market.
Commenting on the report, an analyst from TechNavio’s Healthcare team said: ”The Global Endocrinology Drugs market is witnessing the introduction of innovative and improved drugs and formulations using various drug-delivery technologies. The major players in the Global Endocrinology Drugs market are concentrating on developing new formulations using different drug-delivery routes. Hormone replacement therapy usually involves frequent injections. Novel formulations are using quicker and easier delivery routes than the frequent injections involved in hormone replacement therapy. In order to increase patient compliance, the major players in the Global Endocrinology market are developing novel formulations using various drug-delivery technologies.”
According to the report, the anticipated launch of new molecules such as PLB03002, Arimidex, Pasireotide, and C2L is expected to drive the growth of the market during the forecast period. PLB03002 is a new sustained-release recombinant human growth hormone. It is an improved formulation for the treatment of growth hormone deficiency. Pasireotide is a multireceptor-targeting somatostatin analog. C2L is an improved formulation of Sandostatin LAR. It is an improved formulation of octreotide. It is under investigation for the treatment of acromegaly. Hence, the introduction of new and better drugs is expected to drive the growth of the market.
Further, the report reveals that the expiry of the patents of blockbuster drugs can pose a significant challenge to the growth of the Global Endocrinology Drugs market.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. For further information on this report, please visit https://www.technavio.com/content/global-endocrinology-drugs-market-2012-…
TechNavio, the market research platform of Infiniti Research Ltd, publishes periodic market research reports on niche and emerging technologies. For more information on our Healthcare market research, please visit https://www.technavio.com/healthcare
Follow us on Twitter @ Technavio